Recombinant factor VIIa for long-term replacement therapy in patients with congenital factor VII deficiency

• References

• 1 Perry DJ. Factor VII deficiency.. Blood Coagul Fibrinolysis 2003; 14 (Suppl. 01) S47-54.
• 2 Rivard GE, Kovac I, Kunschak M. et al. Clinical study of recovery and half-life of vapor-heated factor VII concentrate.. Transfusion 1994; 34: 975-979.
• 3 Berrettini M, Mariani G, Schiavonni M. et al. Pharmacokinetic evaluation of recombinant, activated factor VII in patients with inherited factor VII deficiency.. Haematologica 2001; 86: 640-645.
• 4 Ingerslev J, Christiansen K, Sorensen B. International Registry on Factor VII Deficiency (IRF7) Steering Committee.. Inhibitor to factor VII in severe factor VII deficiency: detection and course of the inhibitory response.. J Thromb Haemost 2005; 3: 799-800.
• 5 Mariani G, Herrmann FH, Dolce A. et al. for the International Factor VII Deficiency Study Group. Clinical phenotypes and factor VII genotype in congenital factor VII deficiency.. Thromb Haemost 2005; 93: 481-487.
• 6 Giansily-Blaizot M, Schved JF. Potential predictors of bleeding risk in inherited factor VII deficiency. Clinical, biological and molecular criteria.. Thromb Haemost 2005; 94: 901-906.
• 7 Mariani G, Herrmann FN, Schulman S. et al. for the International Factor VII Deficiency Study Group. Thrombosis in inherited factor VII deficiency.. J Thromb Haemost 2003; 1: 2153-2158.
• 8 Schulman S, Tjonnfjord GE, Wallensten R. et al. Continuous infusion of recombinant factor VIIa for surgery in patients with deficiency of factor VII.. Thromb Haemost 2005; 94: 1177-1180.
• 9 Mariani G, Konkle BA, Ingerslev J. Congenital factor VII deficiency: therapy with recombinant activated factor VII – a critical appraisal.. Haemophilia 2006; 12: 19-27.
• 10 Soucie JM, Siwak EB, Hooper WC. et al. Human parvovirus B19 in young male patients with hemophilia A: associations with treatment product exposure and joint range-of-motion limitation.. Transfusion 2004; 44: 1179-1185.